O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2021ACC: 0001209191-21-015821
Officer· Chief Medical Officer
Since Jun 2018
+180.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
180.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+90.00
Price / share
$17.89
Trade value
$1.61K
% of position
2.6%
2/26/2021
3.42K→3.51K
Total
Net shares
+90.00
Net value
$1.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2021 | A · Award | +90.00 | $17.89 | $1.61K | 2.6% | 3.42K | 3.51K |
| Total | +90.00 | $1.61K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
90.00 shares
Shares
+90.00
Strike price
21.05
Held after
90.00
Exercisable
—
2/26/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock90.00 shares | 2/26/2021 | A · Award | +90.00 | 21.05 | — | 90.00 |